Buscar resultados de ensayos clínicos
Hypereosinophilic Syndrome - 25 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome Condición: Hypereosinophilic Syndrome Fecha: 2005-09-13 Intervenciones: Drug: imatinib mesylate Other Name: Gleevec/Glivec |
Completed |
Nombre del estudio: Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome Condición: Hypereosinophilic Syndrome Fecha: 2001-06-15 Intervenciones: Drug: SCH55700 |
Terminated |
Nombre del estudio: Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome Condición: Hypereosinophilic Syndrome Fecha: 2004-11-22 Intervenciones: Drug: mepolizumab Study Drug |
Recruiting |
Nombre del estudio: Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) Condición: Hypereosinophilic Syndrome Fecha: 2016-07-14 Intervenciones:
|
Recruiting |
Nombre del estudio: Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome Condición: Hypereosinophilic Syndrome Fecha: 2002-08-24 Intervenciones: Drug: Imatinib Mesylate Imatinib is a tyrosine kinase inhibitor that selectively inhibits bcr-abl, c-kit |
Active, not recruiting |
Nombre del estudio: Identification of New Markers in the Hypereosinophilic Syndrome Condición: Hypereosinophilic Syndrome Fecha: 2012-10-22 Intervenciones: Biological: biologie sample comparison of biomarkers between HES, HE biomarkers data and control arms |
Active, not recruiting |
Nombre del estudio: Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome Condición: Hypereosinophilic Syndrome Fecha: 2014-03-14 Intervenciones: Drug: Dexpramipexole Dexpramipexole (KNS 760704) is a synthetic amino-benzothiazole developed for use in |
Recruiting |
Nombre del estudio: Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome Condición: Hypereosinophilic Syndrome Fecha: 2014-04-03 Intervenciones:
|
Completed |
Nombre del estudio: Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) Condición:
Fecha: 2004-07-07 Intervenciones: Drug: mepolizumab |
Withdrawn |
Nombre del estudio: Phase II Gleevec Idiopathic Hypereosinophilic Syndrome Condición:
Fecha: 2005-09-28 Intervenciones: Drug: Gleevec |